Branded Pharmaceuticals / FMCG Pharma - Listed on 09 May 2023
Mankind Pharma (Branded Pharmaceuticals / FMCG Pharma) closed its IPO window in 2023 and listed on NSE and BSE on 09 May 2023 at an upper band issue price of Rs 1080, opening at Rs 1300 for a listing gain of +20.4% and closing day one at Rs 1422.3 (+31.7% on closing basis). The IPO was subscribed 15.32x overall - QIB 49.16x, HNI/NII 3.80x, Retail 0.92x. The total issue size was Rs 4,326.36 Cr (Fresh Issue Rs 0 Cr, OFS Rs 4326.36 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Branded Pharmaceuticals / FMCG Pharma
Mankind Pharma operates in the Branded Pharmaceuticals / FMCG Pharma space. The company’s listed profile is shaped by its operating niche, customer demand and ability to convert that demand into steady cash flows. Investors should read its exchange filings alongside the headline listing numbers for a fuller view of the business.
Issue structure, listing outcome and context
The Mankind Pharma issue was offered at an upper price of Rs 1,080 and raised approximately Rs 4,326.36 crore. The final outcome reflected a mix of subscription demand, valuation, market conditions and the company’s own operating story. Fresh issue and offer-for-sale details, where available, are shown in the issue metrics below.
Number of times each investor category subscribed by close of Day 3.
How overall subscription built up across the three-day issue window.
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | Rs 75 | +6.94% |
| Day 2 | Rs 75 | +6.94% |
| Day 3 | Rs 85 | +7.87% |
| Day 4 | Rs 70 | +6.48% |
| Day 5 | Rs 45 | +4.17% |
Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.
How the broader market moved around the Mankind Pharma IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
Mankind Pharma IPO listed at +20.4% versus the upper issue price of Rs 1,080 on 09 May 2023.
Mankind Pharma IPO was subscribed 15.32x overall. QIB portion was subscribed 49.16x, HNI / NII 3.80x and Retail 0.92x.
IPO GMP started at Rs 75 on Day 1 and moved to Rs 45 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.